Dogwood Financial Statements From 2010 to 2026

DWTX Stock   2.74  0.04  1.44%   
Dogwood Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dogwood Therapeutics' valuation are provided below:
Market Capitalization
89.2 M
Earnings Share
(25.59)
We have found ninety-three available fundamental signals for Dogwood Therapeutics, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Dogwood Therapeutics prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 2.8 M in 2026. Enterprise Value is likely to drop to about 3.6 M in 2026
Check Dogwood Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dogwood Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 78.8 K, Selling General Administrative of 5.3 M or Other Operating Expenses of 9.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0016 or PTB Ratio of 0.0376. Dogwood financial statements analysis is a perfect complement when working with Dogwood Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Dogwood Stock
Check out the analysis of Dogwood Therapeutics Correlation against competitors.
For more information on how to buy Dogwood Stock please use our How to Invest in Dogwood Therapeutics guide.

Dogwood Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets113.9 M108.5 M22.2 M
Slightly volatile
Other Current Liabilities847.2 K1.7 M1.1 M
Pretty Stable
Total Current Liabilities3.8 M3.7 M1.7 M
Slightly volatile
Accounts Payable1.5 M1.4 M405.3 K
Slightly volatile
Cash10.9 M17.1 M5.7 M
Slightly volatile
Non Currrent Assets Other16.7 K16.3 K20.8 K
Slightly volatile
Cash And Short Term Investments10.9 M17.1 M5.7 M
Slightly volatile
Net Receivables385292358
Very volatile
Common Stock Shares Outstanding1.2 M1.2 M418.1 K
Slightly volatile
Liabilities And Stockholders Equity113.9 M108.5 M22.2 M
Slightly volatile
Other Current Assets1.2 MM620.5 K
Slightly volatile
Total Liabilities36.3 M34.5 M7.2 M
Slightly volatile
Total Current Assets12.1 M19 M6.4 M
Slightly volatile
Common Stock1141207.4 M
Slightly volatile
Short and Long Term Debt Total10.6 M17.9 M8.4 M
Slightly volatile
Other Stockholder Equity68.8 M77.7 M61.1 M
Slightly volatile
Net Invested Capital4.5 M4.7 M21.7 M
Slightly volatile
Capital Stock89.8 M85.6 M14.7 M
Slightly volatile
Net Working Capital11 M12 M23 M
Slightly volatile
Long Term Debt12.3 M13.8 M15.1 M
Slightly volatile
Short Term Debt79.5 K89.5 K97.6 K
Slightly volatile
Intangible Assets52.6 M59.1 M64.6 M
Slightly volatile

Dogwood Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense78.8 K83 K151.7 K
Pretty Stable
Selling General Administrative5.3 M10 M3.4 M
Slightly volatile
Other Operating Expenses9.4 M14.1 M5.8 M
Slightly volatile
Research Development4.1 M4.1 M2.4 M
Slightly volatile
Total Operating Expenses9.4 M14.1 M5.8 M
Slightly volatile
Interest Income120.1 K173.5 K86.6 K
Slightly volatile
Depreciation And Amortization9.7 K11 K12 K
Slightly volatile
Cost Of Revenue9.7 K11 K12 K
Slightly volatile

Dogwood Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.6 M3.8 M3.7 M
Slightly volatile
End Period Cash Flow10.9 M17.1 M5.7 M
Slightly volatile
Stock Based Compensation407 K428.4 KM
Slightly volatile
Issuance Of Capital Stock1.2 M1.2 M21.1 M
Slightly volatile
Total Cashflows From Investing ActivitiesM3.4 M3.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.00160.00180.002
Slightly volatile
Average Payables239.1 K308.3 K207.6 K
Slightly volatile
Capex To Depreciation3.0E-44.0E-44.0E-4
Slightly volatile
Cash Per Share15.7816.6115.4917
Slightly volatile
Income Quality0.610.640.6539
Slightly volatile
Intangibles To Total Assets0.660.740.8077
Slightly volatile
Current Ratio6.624.694.0915
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Average Receivables613638566
Slightly volatile
Interest Debt Per Share7.6613.736.5754
Slightly volatile
Debt To Assets0.180.196.8438
Slightly volatile
Ebt Per Ebit1.131.161.0679
Pretty Stable
Effective Tax Rate0.00.00.0
Slightly volatile
Quick Ratio6.624.694.0915
Slightly volatile
Net Income Per E B T0.80.90.9823
Slightly volatile
Cash Ratio5.864.213.6213
Slightly volatile
Debt Ratio0.180.196.8438
Slightly volatile

Dogwood Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.8 M2.9 M53.5 M
Slightly volatile

Dogwood Fundamental Market Drivers

About Dogwood Therapeutics Financial Statements

Dogwood Therapeutics investors use historical fundamental indicators, such as Dogwood Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dogwood Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue11 K9.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dogwood Stock Analysis

When running Dogwood Therapeutics' price analysis, check to measure Dogwood Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics is operating at the current time. Most of Dogwood Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics' price. Additionally, you may evaluate how the addition of Dogwood Therapeutics to your portfolios can decrease your overall portfolio volatility.